Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target
- 1 March 2008
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 109 (1-2) , 1-10
- https://doi.org/10.1016/j.jsbmb.2007.12.010
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Triple-negative breast cancer: therapeutic optionsThe Lancet Oncology, 2007
- Estrogen Receptor-β: Recent Lessons from in Vivo StudiesMolecular Endocrinology, 2007
- Estrogen-Receptor Biology: Continuing Progress and Therapeutic ImplicationsJournal of Clinical Oncology, 2005
- Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line modelThe Journal of Pathology, 2003
- Involvement of estrogen receptor β in terminal differentiation of mammary gland epitheliumProceedings of the National Academy of Sciences, 2002
- Steroid receptors in human breast tumorigenesis and breast cancer progressionBiomedicine & Pharmacotherapy, 2002
- Estrogen Receptor β Is Coexpressed with ERα and PR and Associated with Nodal Status, Grade, and Proliferation Rate in Breast CancerThe American Journal of Pathology, 2000
- Steroid hormone receptors in breast cancer managementBreast Cancer Research and Treatment, 1998
- Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in humanNucleic Acids Research, 1998
- Biology of breast cancer and its clinical implicationsCurrent Opinion in Oncology, 1992